Engflag

Zoderm

Quick links to important sections

Zoderm

Zoderm_IT

Treatment option: Jock Itch, Infection, Shingles, Athlete'S Foot

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zoderm

Property Description
Active ingredient Oxiconazole nitrate
Form Cream and Lotion (Topical)
Pharmacological class Azole Antifungal, Dermatological Preparation
Common use Elimination of superficial fungal pathogens
Origin Synthetic, Imidazole derivative

What Type of Medicine Is Zoderm? (Identity and Classification)

Zoderm is a prescription-only medicine and a dermatological preparation intended for direct use on the skin. Its pharmaceutical identity is derived from its sole active ingredient, Oxiconazole nitrate, which is classified within the azole antifungal class of drugs.

As a synthetic compound, Oxiconazole is further categorized as an imidazole derivative, confirming its status as a single-ingredient product designed specifically to target fungal pathogens. The therapeutic utility of this compound is clinically recognized for its broad activity against various organisms responsible for cutaneous infections. This classification signifies that Zoderm functions as a broad-spectrum antifungal agent developed to provide powerful action against a wide variety of organisms responsible for skin infections.

Composition, Form, and General Purpose

The active component, Oxiconazole nitrate, is delivered through topical application using either a cream or a lotion base, which are the two primary dosage form(s) for this medicine. The availability of both a cream (often used for drier, localized infections) and a lotion (often preferred for larger or hairy areas) distinguishes its formulation, offering flexibility in administration. These specialized topical formulations suspend the Oxiconazole nitrate within a vehicle, such as an emollient cream base or a lighter lotion vehicle.

This focused topical application ensures that the concentration of the active ingredient is maximized precisely at the site of the infection, which is its general purpose and primary benefit. This strategy is essential for the drug to fulfill its role: to control and eliminate the fungal proliferation responsible for superficial dermal infections.

Regulatory References

  1. FDA DailyMed Label for Oxiconazole Nitrate Cream/Lotion

What side effects are possible with Zoderm?

Possible Side Effects and Safety Information

The officially documented safety profile for Oxiconazole nitrate (Zoderm) is primarily defined by local application site reactions, reflecting its topical use and minimal systemic absorption. Adverse reactions are classified according to specific incidence rates documented in clinical trials, rather than standard frequency categories (e.g., common, uncommon).

Documented Adverse Reactions

The majority of reported effects fall under Skin and Subcutaneous Tissue Disorders. These reactions occurred in a small percentage of patients during controlled studies:

Reaction Highest Reported Incidence Rate
Pruritus (Itching) Up to 1.6% (Cream)
Burning Up to 1.4% (Cream)
Irritation Up to 0.4% (Cream)
Stinging Up to 0.7% (Lotion)

Other less frequent local reactions include allergic contact dermatitis, erythema, folliculitis, scaling, and tingling.

Safety Restrictions and Considerations

The primary regulatory restriction is a Contraindication for individuals with known hypersensitivity to oxiconazole nitrate or any component of the formulation. The product is strictly for external dermal use only; introduction into the eyes or vagina must be avoided.

If a reaction suggesting sensitivity or chemical irritation occurs—such as blistering, severe swelling, or oozing—the regulatory documents state that the medicine's use must be discontinued.

Official safety notes also address specific populations. The medicine is classified as Pregnancy Category B and is to be used only if clearly needed. The drug is known to be excreted in human milk, requiring caution during lactation. Safety information for pediatric and geriatric patients indicates that adverse reactions are generally similar to those reported in younger adults.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for this medication is primarily concerned with exposure outside of its intended topical use, given the low rate of systemic absorption through intact skin.

Overdose from topical application is generally considered not likely to cause severe symptoms. However, systemic effects may appear if the cream is applied over a very large area, to damaged skin, or if the product is used with occlusive dressings, particularly in vulnerable populations like infants.

Immediate Emergency Action Required

If the medicine is ingested, it may cause harm, and immediate medical intervention may be required. Contact poison control or local emergency services immediately if ingestion occurs.

Immediate medical attention is also required if any symptoms of a severe allergic reaction occur, as these indicate a medical emergency. These symptoms can include:

  • Shortness of breath or breathing difficulty
  • Swelling of the lips, face, or tongue
  • Closing of the throat
  • Severe dizziness
  • Hives or a spreading skin rash

Regulatory guidance consistently emphasizes that immediate professional medical help must be sought in all cases of suspected ingestion or if severe, systemic allergic reactions are observed.

Therapeutic Uses of Zoderm

Primary Therapeutic Uses of Zoderm

Zoderm is indicated for the topical treatment of superficial fungal infections of the skin. Its primary function is to resolve conditions caused by specific susceptible fungi. These conditions include various forms of tinea infection, which may manifest as athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis). It is also used to address cutaneous candidiasis.

Benefits and Mechanism of Action

The therapeutic benefits of Zoderm are centered on eradicating the fungi responsible for the infection. The treatment aims to clear the infection and mitigate associated symptoms. By disrupting the fungal cell membrane, the medication prevents the growth and spread of the organism. Completing the full course of treatment as prescribed is essential to achieve mycological clearing and reduce the risk of infection recurrence.

Quick Facts: What Zoderm Treats
Superficial fungal skin infections
Tinea infections (e.g., athlete's foot, jock itch, ringworm)
Cutaneous candidiasis
Promotes mycological clearing of the infection

Regulatory References

  1. NIH MedlinePlus guidance on topical antifungals

Eligibility and Restrictions for Use

Zoderm (which may refer to formulations containing Benzoyl Peroxide or Oxiconazole) is typically prescribed to treat various skin conditions, most commonly acne or superficial fungal infections, depending on the active ingredient.

Who Can Use Zoderm?

  • Patients with the specific condition the prescription is intended for (e.g., acne vulgaris for Benzoyl Peroxide formulations, or ringworm/athlete's foot for Oxiconazole formulations).
  • Use in children is generally not recommended below a certain age (often 12 years) unless specifically prescribed by a healthcare provider for conditions like ringworm.

Who Cannot Use Zoderm (Contraindications & Warnings)?

Category Specific Guidance
Allergy/Hypersensitivity Individuals with a known hypersensitivity or allergy to the active ingredient (Benzoyl Peroxide or Oxiconazole) or any of the product's excipients should not use Zoderm.
Pregnancy Use during pregnancy is advised only if clearly needed and the potential benefit justifies the potential risk to the fetus. It is generally contraindicated in the first trimester for Oxiconazole-containing products.
Breastfeeding Caution is advised. It is unknown if the drug is excreted in human milk. Consult a doctor, and avoid application to the nipple/breast area to prevent infant ingestion.
Skin Conditions Certain formulations may be inappropriate for use on broken skin, wounds, eczema, or in the presence of severe irritation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Zoderm's interaction profile, due to its topical administration and minimal systemic absorption, primarily focuses on interactions at the application site rather than internal organ systems. Official regulatory information suggests a low risk for systemic pharmacokinetic interactions.

Documented Topical and Physical Incompatibilities

The most significant documented interactions involve co-administration with other topical products, which may lead to additive irritation or physical reactions. This information applies primarily to the Benzoyl Peroxide formulation of Zoderm.

Product Category Interaction Implication Constraint/Requirement
Other Topical Agents (e.g., Tretinoin) Increased local irritation and skin effects. Avoid simultaneous use on the same area.
Sunscreens (PABA-containing) Risk of temporary skin discoloration. Avoid combining with Zoderm.
Harsh Cleansers/Cosmetics Increased local irritation/abrasion. Avoid use on the treated area.

For the Oxiconazole formulation (Zoderm E), systemic interactions, including those with alcohol or involving major organ function (hepatic/renal), are officially classified as not known or not established due to the minimal systemic drug levels. Patients are advised to inform their healthcare provider about recent use of steroid creams or a history of allergic reactions to other antifungal medicines. The overall interaction structure emphasizes local incompatibility avoidance rather than systemic drug-drug conflicts.

Mechanism of Action

Modulation of Fungal Cell Membrane Integrity

This mechanism, relevant to azole derivative formulations, involves Oxiconazole targeting the ergosterol biosynthesis pathway. The compound functions as an inhibitor of the fungal enzyme lanosterol 14-alpha demethylase. This interaction prevents the conversion of lanosterol into ergosterol, a vital sterol required for the structural and functional integrity of the fungal cell membrane. The resultant pathway disruption facilitates the accumulation of intermediary sterols and leads to the structural and functional destabilization of the cell membrane.

Generation of Oxygen Free Radicals

This domain is associated with Benzoyl Peroxide formulations. The compound acts as an oxidizing agent that decomposes upon application, releasing oxygen free radicals locally within the pilosebaceous unit. These reactive species engage in non-specific oxidative damage to prokaryotic structures. This cascade additionally affects the modulation of follicular epithelial cell turnover.

Dosage and Administration Information

How to Use Zoderm (Oxiconazole Nitrate)

The administration of Zoderm is governed by specific instructions defining the correct method and duration of application. The medicine is available as a 1% cream or 1% lotion and is for topical dermal use only, meaning it must be applied directly to the skin. It is strictly prohibited for oral, ophthalmic, or intravaginal use.

Official Administration and Dosing

Usage Aspect Official Instruction
Application Site Apply to the affected area and the immediately surrounding areas.
Frequency Once to twice daily for tinea pedis, tinea corporis, and tinea cruris. Once daily for tinea versicolor.
Duration of Course 2 weeks for tinea corporis, tinea cruris, and tinea versicolor. 1 month (4 weeks) for tinea pedis.

Procedural and Population Rules

For proper administration, the lotion formulation requires the bottle to be shaken well before application. Patients should gently rub the product into the skin until it is mostly absorbed and use the medication for the full treatment time recommended to complete the course.

Regarding specific populations, no dose adjustment is warranted for older adult patients (geriatric use). The medication may also be used for the approved tinea indications in pediatric patients, although these infections are uncommon in those under the age of 12. Patients are also instructed to avoid the use of occlusive dressings (e.g., tight bandages) over the application site unless otherwise directed by a healthcare professional.

Recent Clinical Evidence

Research evidence / Overview of Studies for Zoderm

Evidence for Tinea Pedis (Athlete's Foot)

Research exploring the use of Zoderm for tinea pedis has primarily been conducted through short-term, randomized controlled trials (RCTs) and multicenter studies, including adults and adolescents (≥ 12 years). The main outcomes measured were Mycological Cure, defined as the absence of fungus based on laboratory tests, and Clinical Cure, defined by the measured evolution of visible signs like scaling and redness. The available research provides context but not individual predictions regarding short-term mycological and clinical outcomes.

Evidence for Tinea Cruris (Jock Itch) and Tinea Corporis (Ringworm)

Zoderm was studied for both tinea cruris and tinea corporis in randomized clinical trials over a typically shorter, two-week course. Research examined patient populations of adults and adolescents, focusing on the principal endpoints of Clinical Cure and Mycological Cure at the end of the treatment phase and at a follow-up visit. Evidence concerning the sustained outcomes over a longer period is generally limited.

Evidence in Specific Patient Groups and Gaps

Research for Zoderm was evaluated in primarily adults and adolescents; as such, results apply only to the populations studied. Research examining short-term symptom changes in groups such as children under the age of 12 or frail older adults is insufficient.

One key limitation is that long-term effects are not fully established beyond the short post-treatment observation window. Furthermore, while Zoderm was studied for comparative outcomes against older topical treatments, comparative evidence is lacking against the newest antifungal medications on the market, limiting the ability to draw comprehensive conclusions about comparative outcomes across all available options.

Key Studies & References

  1. Oxiconazole Nitrate Cream and Lotion FDA Approved Label (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Zoderm (FAQ)

Q: Can I stop taking this medication suddenly?

Regulatory documents state that suddenly stopping Zoderm may lead to potential side effects or symptoms related to withdrawal. This is often the case with medicines that affect the central nervous system or certain hormonal systems.

Official product information emphasizes the potential need for a gradual dose reduction, a process that must be overseen by a healthcare professional.

Q: Does it make you sleepy or affect driving?

Yes, regulatory information indicates that Zoderm may cause central nervous system effects such as dizziness and drowsiness. These are listed as potential side effects.

Official sources caution that Zoderm may impair a person's ability to safely drive or operate heavy machinery due to potential CNS effects.

Q: How should I store this medicine?

The official product information specifies how Zoderm should be stored to maintain its quality and stability.

Generally, this medicine is kept at room temperature, which is typically between 68 mathrmF and 77 mathrmF (or 20 mathrmC and 25 mathrmC). The regulatory information indicates that Zoderm should also be protected from moisture and light during storage.

How should Zoderm be stored and disposed of?

How to Store and Dispose of Zoderm (Oxiconazole Nitrate)

Zoderm (oxiconazole nitrate) cream and lotion must be stored according to specific regulatory requirements to maintain product stability.

Storage Requirements

The product must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted short excursions up to 30 C (86 F). The container must be kept tightly closed and stored away from heat, moisture, and direct light. It is mandatory that the medicine not be frozen.

Handling and Disposal

Zoderm must be kept out of the reach of children at all times. Regarding disposal, the product should not be kept if outdated or no longer needed. If a drug take-back program is unavailable, unused medicine should be mixed with an undesirable substance (such as dirt or coffee grounds) and placed in a sealed container before being thrown into household trash, following established regulatory guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagIndia

Equivalent of Zoderm found in:

A-Z Index: